Your browser doesn't support javascript.
loading
Psychedelics: preclinical insights provide directions for future research.
Gumpper, Ryan H; Roth, Bryan L.
Afiliação
  • Gumpper RH; Department of Pharmacology, UNC School of Medicine, Chapel Hill, NC, 27514, USA.
  • Roth BL; Department of Pharmacology, UNC School of Medicine, Chapel Hill, NC, 27514, USA. bryan_roth@med.unc.edu.
Neuropsychopharmacology ; 49(1): 119-127, 2024 Jan.
Article em En | MEDLINE | ID: mdl-36932180
ABSTRACT
Recently, psychedelics have emerged as promising therapeutics for numerous neuropsychiatric disorders. While their potential in the clinic has yet to be fully elucidated, understanding their molecular and biological mechanisms is imperative as these compounds are becoming widely used both in therapeutic and recreational contexts. This review examines the current understanding of basic biology, pharmacology, and structural biology in an attempt to reveal both the knowns and unknowns within the field.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos Idioma: En Revista: Neuropsychopharmacology Assunto da revista: NEUROLOGIA / PSICOFARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos Idioma: En Revista: Neuropsychopharmacology Assunto da revista: NEUROLOGIA / PSICOFARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos